
S H Kelkar & Company Q2 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
No
Order
Yes
Capex
Yes
2 of 5 growth signals are positive.
Full analysisRevenue guidance
Category 3- Management expects a 12% medium-term CAGR growth in revenue, with confidence in sustaining this trend (Page 6).
- Volume growth is projected to be double-digit, driven by market share gains, especially from new global MNC clients and large corporates (Pages 14, 15).
- The Fragrance segment is expected to grow at over 12% CAGR, while the Flavour segment targets around 15% CAGR growth (Page 10).
- Growth is supported by a mix of new and existing products, with new products contributing around 3-6% to revenues (Page 5).
- Export business remains seasonal and uncertain short-term but expected to recover long-term (Page 10).
- The company sees upside risk beyond the 12% growth guidance due to ongoing RFQs and new customer acquisitions (Page 10).
- Strategic efforts via backward integration and new product launches will aid sustainable volume and revenue growth.
See what S H Kelkar & Company management said on margin guidance — free account, 30 seconds.
Fundraise plans
No- There are no immediate plans to repay the debt as of now.
- Current operations are generating free cash flow, which is progressively reducing debt.
- Recent investments have been concluded in the Indonesia plant and the Holland Aromatics acquisition.
- No large deployments or new investments are foreseen in the next couple of quarters.
- Debt levels are expected to start coming down after this period.
- The company plans to maintain net debt to EBITDA ratio below 2x as a priority.
- There is no mention of any new fundraising through debt or equity in the near term.
See what S H Kelkar & Company management said on order book — free account, 30 seconds.
Capex plans
Yes- Recently concluded investments in the Indonesia plant and the acquisition of Holland Aromatics.
- Indonesia factory is expected to commence by the end of the current financial year, enhancing capacity for Middle East and Southeast Asia markets.
- No immediate plans for new capacity investment in Europe; will assess market conditions over the next year or two before deciding.
- Plans to augment India capacity by supporting export business from the India plant, leveraging the new Indonesia facility.
- Backward integration for Global Ingredients scheduled for completion in Q4 FY24, expected to improve supply chain resilience and cost competitiveness.
- No large capital deployments anticipated in the next couple of quarters; operational cash flow used to reduce debt progressively.
Track S H Kelkar & Company — get its next earnings analysis in your feed
How does S H Kelkar & Company rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does S H Kelkar & Company rank in Chemicals & Petrochemicals?
Compare S H Kelkar & Company against every Chemicals & Petrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.
Continue your research
What S H Kelkar & Company's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…